Results
134
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
134 companies
GenMont Biotech Incorporation
Market Cap: NT$1.7b
Engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan.
3164
NT$19.95
7D
-1.0%
1Y
-11.5%
Pet Pharm Biotech
Market Cap: NT$3.7b
Manufactures and sells pharmaceutical products.
7762
NT$73.80
7D
19.4%
1Y
127.8%
Bio Preventive Medicine
Market Cap: NT$1.3b
Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases.
6810
NT$26.00
7D
-4.1%
1Y
-15.9%
Lotus Pharmaceutical
Market Cap: NT$52.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$200.50
7D
-9.5%
1Y
-27.1%
Welgene BiotechLtd
Market Cap: NT$498.7m
Provides genetic testing services.
6661
NT$21.40
7D
6.5%
1Y
-24.9%
Energenesis BiomedicalLTD
Market Cap: NT$5.3b
Operates in the biomedicine industry in Taiwan.
6657
NT$59.90
7D
4.2%
1Y
15.0%
Medigen Biotechnology
Market Cap: NT$4.2b
A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.
3176
NT$30.40
7D
-1.9%
1Y
-21.0%
Gwo Xi Stem Cell Applied Technology
Market Cap: NT$2.2b
Develops stem cell medicines for patients with unmet medical needs.
6704
NT$22.65
7D
-1.5%
1Y
-31.4%
Taho Pharmaceuticals
Market Cap: NT$5.6b
A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.
6467
NT$108.00
7D
14.4%
1Y
n/a
Tanvex BioPharma
Market Cap: NT$13.1b
A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.
6541
NT$55.00
7D
3.2%
1Y
5.8%
Lin BioScience
Market Cap: NT$13.3b
A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.
6696
NT$161.00
7D
-0.6%
1Y
74.2%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$1.5b
Engages in the development of drugs for the treatment of advanced and refractory cancers.
7427
NT$33.55
7D
-5.0%
1Y
-16.7%
MegaPro Biomedical
Market Cap: NT$1.2b
A biotech company, focuses on the development of nano drugs.
6827
NT$18.50
7D
5.1%
1Y
-2.6%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.3b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$73.60
7D
0.3%
1Y
-19.3%
3D Global Biotech
Market Cap: NT$3.1b
Develops medical materials for human body reconstruction in China.
6808
NT$40.00
7D
-13.6%
1Y
12.7%
Steminent Biotherapeutics
Market Cap: NT$2.0b
A stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs.
7729
NT$36.25
7D
27.9%
1Y
59.3%
Enimmune
Market Cap: NT$1.2b
Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.
6564
NT$16.60
7D
0.3%
1Y
-51.7%
TaiMed Biologics
Market Cap: NT$21.8b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$79.70
7D
1.1%
1Y
-1.5%
BioLASCO Taiwan
Market Cap: NT$836.2m
Provides bio-materials and surgical services in Taiwan and internationally.
6662
NT$32.65
7D
0%
1Y
-10.2%
Golden Biotechnology
Market Cap: NT$1.8b
Operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.
4132
NT$11.10
7D
-1.8%
1Y
-46.2%
Handa Pharmaceuticals
Market Cap: NT$12.8b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$80.80
7D
-1.3%
1Y
-7.3%
BioGend Therapeutics
Market Cap: NT$4.5b
Researches, develops, and sells orthopedic medical equipment and related products.
6733
NT$36.55
7D
22.7%
1Y
8.5%
Cenra
Market Cap: NT$5.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$34.40
7D
0%
1Y
n/a
TaiGen Biopharmaceuticals Holdings
Market Cap: NT$6.5b
A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.
4157
NT$9.12
7D
10.8%
1Y
-37.3%
Genovate Biotechnology
Market Cap: NT$2.1b
Engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan.
4130
NT$18.70
7D
0.3%
1Y
-15.3%
Nang Kuang Pharmaceutical
Market Cap: NT$3.6b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$35.60
7D
0.8%
1Y
-21.8%